Catalyst Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2022 Total Revenues and Provides Full Year 2023 Revenue Guidance
2022 Total Revenues Estimated at $214 Million, Representing 52% YoY Growth Forecast 2023 Total Revenues of…
Month: February 2023
Pliant Therapeutics to Participate in Upcoming Investor Events
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) — Pliant Therapeutics, Inc. (Nasdaq: PLRX),…
Selecta Biosciences to Participate at the SVB Securities Global Biopharma Conference
WATERTOWN, Mass., Feb. 07, 2023 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…
RAPT Therapeutics to Participate in the SVB Securities Global Biopharma Conference
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT),…
Keros Therapeutics to Present at the SVB Securities Global Biopharma Conference
LEXINGTON, Mass., Feb. 07, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a…
Orchestra BioMed Strengthens Senior Leadership Team
Avi Fischer, M.D., joins as SVP, Medical Affairs and Innovation; J.C. Simeon assumes role of…
Ascendis Pharma Announces Full Year 2022 Financial Results and Business Update Conference Call on February 16
COPENHAGEN, Denmark, Feb. 07, 2023 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced…
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
Ulixacaltamide (PRAX-944) Phase 2b Essential1 study topline results for essential tremor expected in 1Q23; Praxis…
Immix Biopharma Announces Dosing of First 2 Patients in its IMX-110 + BeiGene/Novartis anti-PD-1 Tislelizumab Phase 1b/2a Combination Clinical Trial in Patients with Advanced Cancer
IMX-110 + Beigene/Novartis anti-PD-1 Tislelizumab combination designed to enhance response to solid tumors by turning…
CENTOGENE Regains Compliance With Nasdaq Listing Requirements
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Feb. 07, 2023 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq:…
Replimune to Present at the Virtual SVB Securities Global Biopharma Conference
WOBURN, Mass., Feb. 07, 2023 (GLOBE NEWSWIRE) — Replimune Group, Inc. (Nasdaq: REPL), a clinical…
Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
Topline Data Expected in 2Q 2023 SEATTLE, Wash and VANCOUVER, British Columbia, Feb. 07, 2023…
Viridian Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference
WALTHAM, Mass., Feb. 07, 2023 (GLOBE NEWSWIRE) — Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company…
PharmaTher Submits FDA Meeting Package to Discuss 505(b)(2) Pathway for New Drug Application of KETARX™ (Ketamine) On-Body Pump System
Figure 1 Proposed KETARX™ on-body kit and application. Not FDA approved. Not for sale. TORONTO,…
Avicanna Expands its Partnership with Viola Brands to the United Kingdom
Avicanna Expands its Partnership with Viola Brands to the United Kingdom The initial line of…
Verizon achieves upload speeds surpassing 1 GBPS
PHOENIX, Feb. 07, 2023 (GLOBE NEWSWIRE) — Verizon engineers continue to drive the evolution of…
Baffle Makes Multi-Tenant Data Security for SaaS Providers Even Easier
Record-level Encryption Isolates Customer Data; BYOK Gives Customers Complete Control SANTA CLARA, Calif., Feb. 07, 2023…
AvidXchange Launches AvidAnalytics, A Business Intelligence Tool for the Middle Market
New premium business intelligence solution offers spend management capabilities beyond standard industry reporting CHARLOTTE, N.C.,…
2022 Marks Another Successful Year for InterPro with Product Enhancements, New Clients, Industry Awards, and a Top 1% Net Promoter Score
Leading Maximo mobile provider wins industry recognition, enhances product suite, and gains market share. STONEHAM,…
Cerence Enhances the Driving Experience for Legendary Automaker’s Tour Guide Feature
Leading German OEM is the first automaker to leverage Cerence Tour Guide to enable professional…